Review of Toxicities of PARP Inhibitors in Metastatic Castrate Resistant Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Review of Toxicities of PARP Inhibitors in Metastatic Castrate Resistant Prostate Cancer

Published:2023-02 Issue:1 Volume:21 Page:183-193
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Nindra Udit^ORCID,Hong Jun Hee,Balakrishnar Bavanthi,Pal Abhijit,Chua Wei

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference32 articles.

1. Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial;Mateo;Lancet Oncol,2020

2. PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic review;Ratta;Prostate Cancer Prostatic Dis,2020

3. The 2014 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system;Epstein;Am J Surg Pathol,2016

4. DNA Damage repair deficiency in prostate cancer;Burdak-Rothkamm;Trends Cancer,2020

5. BRCA mutations in prostate cancer: prognostic and predictive implications;Messina;J Oncol,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A panel‐based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration‐resistant prostate cancer;The Prostate;2024-09-09

2. Molecular heterogeneity in prostate cancer and the role of targeted therapy;Life Sciences;2024-01

3. Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer;International Journal of Molecular Sciences;2023-12-20

4. Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis;Targeted Oncology;2023-11-22

5. Hematological Toxicities with PARP Inhibitors in Prostate Cancer: A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials;Cancers;2023-10-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3